Ganciclovir Oresund Pharma 500 mg Noorwegen - Noors - Statens legemiddelverk

ganciclovir oresund pharma 500 mg

oresund pharma aps - ganciklovirnatrium - pulver til konsentrat til infusjonsvæske, oppløsning - 500 mg

Carbamazepine Essential Pharma 125 mg Noorwegen - Noors - Statens legemiddelverk

carbamazepine essential pharma 125 mg

essential pharma (m) limited - karbamazepin - stikkpille - 125 mg

Carbamazepine Essential Pharma 250 mg Noorwegen - Noors - Statens legemiddelverk

carbamazepine essential pharma 250 mg

essential pharma (m) limited - karbamazepin - stikkpille - 250 mg

Ebvallo Europese Unie - Noors - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Brimica Genuair Europese Unie - Noors - EMA (European Medicines Agency)

brimica genuair

covis pharma europe b.v. - formoterol fumarate dihydrate, aclidinium bromide - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - brimica genuair er indikert som vedlikeholdsbronkodilatorbehandling for luftstrømningsobstruksjon og lindring av symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kol).

Oxybee Europese Unie - Noors - EMA (European Medicines Agency)

oxybee

dany bienenwohl gmbh - oksalsyre dihydrat - ectoparasiticides for utvortes bruk, inkl. insektmidler - bees - for behandling av varroosis (varroa destructor) av honning bier (apis mellifera) i brood-gratis kolonier.

Yana 2 mg / 0.03 mg Noorwegen - Noors - Statens legemiddelverk

yana 2 mg / 0.03 mg

heaton k.s - dienogest / etinyløstradiol - tablett, filmdrasjert - 2 mg / 0.03 mg

Intuniv Europese Unie - Noors - EMA (European Medicines Agency)

intuniv

takeda pharmaceuticals international ag ireland branch - guanfacin hydroklorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv må brukes som en del av en omfattende adhd behandling program, vanligvis inkludert psykologiske, pedagogiske og sosiale tiltak.

Lamivudine Teva Pharma B.V. Europese Unie - Noors - EMA (European Medicines Agency)

lamivudine teva pharma b.v.

teva b.v.  - lamivudin - hiv-infeksjoner - antivirale midler til systemisk bruk - lamivudin teva pharma b. indikeres som en del av antiretroviral kombinationsbehandling for behandling av humane immunsviktvirus (hiv) -infiserte voksne og barn.

Inrebic Europese Unie - Noors - EMA (European Medicines Agency)

inrebic

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiske midler - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.